CONTROLLED RELEASE 25-HYDROXYVITAMIN D
The invention provides a pharmaceutical composition comprising an oral formulation of 25-hydroxyvitamin D3 for use in a method of treatment of secondary hyperparathyroidism in a human patient having chronic kidney disease. The method of treatment comprises administering the composition to the patien...
Gespeichert in:
Hauptverfasser: | , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; hun |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | White, Jay A Bishop, Charles W Crawford, Keith H Petkovich, P. Martin Messner, Eric J Tabash, Samir P Agudoawu, Sammy A |
description | The invention provides a pharmaceutical composition comprising an oral formulation of 25-hydroxyvitamin D3 for use in a method of treatment of secondary hyperparathyroidism in a human patient having chronic kidney disease. The method of treatment comprises administering the composition to the patient and the patient is treated without causing supraphysiological surges in blood levels of 25-hydroxyvitamin D3. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_HUE063590TT2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>HUE063590TT2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_HUE063590TT23</originalsourceid><addsrcrecordid>eNrjZFBz9vcLCfL38XF1UQhy9XF1DHZVMDLV9Yh0CfKPiAzzDHH09fRTcOFhYE1LzClO5YXS3AyKbq4hzh66qQX58anFBYnJqXmpJfEeoa4GZsamlgYhIUbGxKgBANQHJC0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>CONTROLLED RELEASE 25-HYDROXYVITAMIN D</title><source>esp@cenet</source><creator>White, Jay A ; Bishop, Charles W ; Crawford, Keith H ; Petkovich, P. Martin ; Messner, Eric J ; Tabash, Samir P ; Agudoawu, Sammy A</creator><creatorcontrib>White, Jay A ; Bishop, Charles W ; Crawford, Keith H ; Petkovich, P. Martin ; Messner, Eric J ; Tabash, Samir P ; Agudoawu, Sammy A</creatorcontrib><description>The invention provides a pharmaceutical composition comprising an oral formulation of 25-hydroxyvitamin D3 for use in a method of treatment of secondary hyperparathyroidism in a human patient having chronic kidney disease. The method of treatment comprises administering the composition to the patient and the patient is treated without causing supraphysiological surges in blood levels of 25-hydroxyvitamin D3.</description><language>eng ; hun</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240128&DB=EPODOC&CC=HU&NR=E063590T2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76516</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240128&DB=EPODOC&CC=HU&NR=E063590T2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>White, Jay A</creatorcontrib><creatorcontrib>Bishop, Charles W</creatorcontrib><creatorcontrib>Crawford, Keith H</creatorcontrib><creatorcontrib>Petkovich, P. Martin</creatorcontrib><creatorcontrib>Messner, Eric J</creatorcontrib><creatorcontrib>Tabash, Samir P</creatorcontrib><creatorcontrib>Agudoawu, Sammy A</creatorcontrib><title>CONTROLLED RELEASE 25-HYDROXYVITAMIN D</title><description>The invention provides a pharmaceutical composition comprising an oral formulation of 25-hydroxyvitamin D3 for use in a method of treatment of secondary hyperparathyroidism in a human patient having chronic kidney disease. The method of treatment comprises administering the composition to the patient and the patient is treated without causing supraphysiological surges in blood levels of 25-hydroxyvitamin D3.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFBz9vcLCfL38XF1UQhy9XF1DHZVMDLV9Yh0CfKPiAzzDHH09fRTcOFhYE1LzClO5YXS3AyKbq4hzh66qQX58anFBYnJqXmpJfEeoa4GZsamlgYhIUbGxKgBANQHJC0</recordid><startdate>20240128</startdate><enddate>20240128</enddate><creator>White, Jay A</creator><creator>Bishop, Charles W</creator><creator>Crawford, Keith H</creator><creator>Petkovich, P. Martin</creator><creator>Messner, Eric J</creator><creator>Tabash, Samir P</creator><creator>Agudoawu, Sammy A</creator><scope>EVB</scope></search><sort><creationdate>20240128</creationdate><title>CONTROLLED RELEASE 25-HYDROXYVITAMIN D</title><author>White, Jay A ; Bishop, Charles W ; Crawford, Keith H ; Petkovich, P. Martin ; Messner, Eric J ; Tabash, Samir P ; Agudoawu, Sammy A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_HUE063590TT23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; hun</language><creationdate>2024</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>White, Jay A</creatorcontrib><creatorcontrib>Bishop, Charles W</creatorcontrib><creatorcontrib>Crawford, Keith H</creatorcontrib><creatorcontrib>Petkovich, P. Martin</creatorcontrib><creatorcontrib>Messner, Eric J</creatorcontrib><creatorcontrib>Tabash, Samir P</creatorcontrib><creatorcontrib>Agudoawu, Sammy A</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>White, Jay A</au><au>Bishop, Charles W</au><au>Crawford, Keith H</au><au>Petkovich, P. Martin</au><au>Messner, Eric J</au><au>Tabash, Samir P</au><au>Agudoawu, Sammy A</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>CONTROLLED RELEASE 25-HYDROXYVITAMIN D</title><date>2024-01-28</date><risdate>2024</risdate><abstract>The invention provides a pharmaceutical composition comprising an oral formulation of 25-hydroxyvitamin D3 for use in a method of treatment of secondary hyperparathyroidism in a human patient having chronic kidney disease. The method of treatment comprises administering the composition to the patient and the patient is treated without causing supraphysiological surges in blood levels of 25-hydroxyvitamin D3.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng ; hun |
recordid | cdi_epo_espacenet_HUE063590TT2 |
source | esp@cenet |
subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
title | CONTROLLED RELEASE 25-HYDROXYVITAMIN D |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-16T05%3A07%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=White,%20Jay%20A&rft.date=2024-01-28&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EHUE063590TT2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |